proline and Cognition Disorders

proline has been researched along with Cognition Disorders in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's1 (10.00)18.2507
2000's3 (30.00)29.6817
2010's5 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, YR; Ji, M; Liu, DQ; Liu, RT; Wang, SW; Xie, XX; Yu, XL; Zhang, LX; Zhang, Y1
Hattori, M; Horiguchi, T; Iwashita, H; Matsumoto, Y; Nakamura, K; Obayashi, Y; Onishi, T; Yano, T1
Gil-Pisa, I; Giralt, E; Gómez, L; Meana, JJ; Mendieta, L; Munarriz-Cuezva, E; Prades, R; Royo, S; Tarragó, T; Urigüen, L1
Chen, XN; Chen, XP; He, S; Li, LX; Luo, XJ; Peng, Y; Wan, LY; Wu, K1
Borghgraef, P; Demedts, D; Devijver, H; Kremer, A; Maurin, H; Van Leuven, F1
Arias, B; Barrantes-Vidal, N; Catalán, R; Fañanás, L; Guitart, M; Papiol, S; Salgado, P1
Selley, ML1
Beamer, B; Cummings, SR; Harris, T; Hsueh, WC; Kanaya, AM; Li, R; Lindquist, K; Newman, A; Rosano, C; Yaffe, K1
Badskjaer, J; Jørgensen, F; Nordin, H1

Other Studies

10 other study(ies) available for proline and Cognition Disorders

ArticleYear
Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau.P301S mouse model of Alzheimer's disease and frontotemporal dementia.
    Alzheimer's research & therapy, 2018, 06-19, Volume: 10, Issue:1

    Topics: Alzheimer Disease; Animals; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Immunologic; Exploratory Behavior; Female; Frontotemporal Dementia; Hepatitis B Vaccines; Immunization; Immunodominant Epitopes; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Nerve Tissue Proteins; Proline; Recognition, Psychology; Serine; tau Proteins; Treatment Outcome; Vaccines, Virus-Like Particle

2018
Early-onset cognitive deficits and axonal transport dysfunction in P301S mutant tau transgenic mice.
    Neuroscience research, 2014, Volume: 80

    Topics: Age Factors; Animals; Axonal Transport; Cognition Disorders; Disease Progression; Exploratory Behavior; Gene Expression Regulation; Humans; Maze Learning; Mice; Mice, Transgenic; Motor Activity; Mutation; Nerve Tissue Proteins; Phosphorylation; Proline; Recognition, Psychology; Serine; tau Proteins

2014
The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2017, Volume: 27, Issue:2

    Topics: Animals; Cell Line, Tumor; Cognition; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Male; Maze Learning; Mice, Inbred C57BL; Motor Activity; Poly I-C; Prepulse Inhibition; Proline; Prolyl Oligopeptidases; Psychotropic Drugs; Recognition, Psychology; Schizophrenia; Schizophrenic Psychology; Serine Endopeptidases; Serine Proteinase Inhibitors

2017
[Association of PPARgamma2 Pro12Ala polymorphism and cognitive dysfunction in hypertension patients].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2010, Volume: 41, Issue:6

    Topics: Aged; Alanine; Alleles; Cognition Disorders; Female; Gene Frequency; Humans; Hypertension; Male; Middle Aged; Polymorphism, Genetic; PPAR gamma; Proline

2010
Early improved and late defective cognition is reflected by dendritic spines in Tau.P301L mice.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011, Dec-07, Volume: 31, Issue:49

    Topics: Age Factors; Animals; Bacterial Proteins; Brain; Cells, Cultured; Cognition Disorders; Dendritic Spines; Disease Models, Animal; Female; Humans; Leucine; Luminescent Proteins; Male; Mice; Mice, Transgenic; Neurons; Phosphorylation; Proline; Synaptosomes; tau Proteins

2011
Analysis of polymorphisms at the tumor suppressor gene p53 (TP53) in contributing to the risk for schizophrenia and its associated neurocognitive deficits.
    Neuroscience letters, 2004, Jun-03, Volume: 363, Issue:1

    Topics: Adult; Alleles; Arginine; Chi-Square Distribution; Cognition Disorders; DNA Transposable Elements; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Polymorphism, Genetic; Proline; Risk; Schizophrenia; Tumor Suppressor Protein p53

2004
Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons.
    Journal of neuroscience research, 2004, Jul-01, Volume: 77, Issue:1

    Topics: Alzheimer Disease; Amidohydrolases; Animals; Antioxidants; Arginine; Brain; Cells, Cultured; Cognition Disorders; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Feedback, Physiological; Homocysteine; Neurons; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase; Proline; Rats; Thiocarbamates; Up-Regulation

2004
PPAR-gamma Pro12Ala genotype and risk of cognitive decline in elders.
    Neurobiology of aging, 2008, Volume: 29, Issue:1

    Topics: Aged; Aging; Alanine; Black People; Cognition Disorders; Female; Genotype; Humans; Longitudinal Studies; Male; Mental Status Schedule; Neuropsychological Tests; PPAR gamma; Proline; Retrospective Studies; Risk; White People

2008
Captopril and resistant ascites.
    Lancet (London, England), 1983, Aug-13, Volume: 2, Issue:8346

    Topics: Ascites; Captopril; Cognition Disorders; Confusion; Diuretics; Drug Synergism; Humans; Male; Middle Aged; Proline

1983
Fasoracetam. LAM 105, NS 105.
    Drugs in R&D, 1999, Volume: 2, Issue:2

    Topics: Animals; Clinical Trials as Topic; Cognition Disorders; Humans; Nootropic Agents; Piperidines; Proline; Rats; Rats, Wistar

1999